Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia

Anaheim

Glendale

Irvine

Long Beach

Los Angeles

Oakland

San Bernardino

San Diego

Torrance

Hockessin

Bradenton

Hialeah

Kissimmee

Miami

North Miami

Orlando

Honolulu

Chicago

Shreveport

Natick

Worcester

Ann Arbor

St Louis

Lincoln

Omaha

Nashua

Buffalo

New York

Rochester

High Point

Dayton

Oklahoma City

Conshohocken

Norristown

Phoenixville

Scranton

DeSoto

Fort Worth

Houston

Irving

Petersburg

Seattle

Spokane

Vancouver

London

Toronto

Montreal

San Juan